Episode Synopsis "Eliminating Chemotherapy - TailorX Study Results. Dr. Joseph Sparano Series 2/Episode 8"

Chemotherapy has been a gold standard for treatment of breast cancer and often over-treats women who may not need this aggressive treatment to treat their breast cancer.  Dr. Sparano serves as the study chair for the TAILORx clinical trial sponsored by National Cancer Institute, the first clinical trial integrating a mulitparameter gene expression assay in clinical decision making for adjuvant therapy with early stage ER-positive, HER2 negative breast cancer.  The results will eliminate the use of chemotherapy for thousands of women.

Listen "Eliminating Chemotherapy - TailorX Study Results. Dr. Joseph Sparano Series 2/Episode 8"

More episodes of the podcast Susan G. Komen Austin

• Biosimilars for Breast Cancer May Provide More Treatment Options
• Targeted Therapies, Biologics and Biosimilars for Breast Cancer Treatment - Dr. Keith Knutson
• Barriers in Healthcare - The Latino Community Challenge
• What is natural after breast cancer? Dr. Christine Fisher
• Eliminating Chemotherapy - TailorX Study Results. Dr. Joseph Sparano Series 2/Episode 8
• MORE THAN PINK S4 EP2 - Becoming Whole Again - Dr. Elisabeth Potter